Baclofen Use in CKD and Risk of Encephalopathy

This pharmacoepidemiology study uses Canadian health care database data to estimate the risk of encephalopathy among patients with chronic kidney disease (CKD) in Ontario prescribed higher ( ≥20 mg) vs lower (<20 mg) doses of baclofen.

https://jamanetwork.com/journals/jama/fullarticle/2754806

Source: JAMA - Journal of the American Medical Association - November 9, 2019 Category: General Medicine Source Type: research